Challenges of phase III trial design for novel treatments in diseases with no standard treatment: the AZA-001 myelodysplasia study model. (2014)

First Author: Fenaux P

Attributed to: MRC Centre for Transplantation funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.leukres.2013.10.014

PubMed Identifier: 24360612

Publication URI: http://europepmc.org/abstract/MED/24360612

Type: Journal Article/Review

Volume: 38

Parent Publication: Leukemia research

Issue: 2

ISSN: 0145-2126